Group of Takeda investors try to block Shire deal; FDA’s Gottlieb threatens to pull e-cigarettes completely; AstraZeneca’s immunotherapy fails late-stage lung cancer trial.
FDA imposes restrictions on e-cigarette sales; Pfizer launches biosimilar to treat anemia; J&J cleared of liability in one talc case.
Healthcare leaders expect to spend an average of $32 million implementing artificial intelligence into their business.
The drugmaker will raise prices on 10% of its drug portfolio.
A portion of all proceeds from nominations will be donated to the nonprofit.
Juul suspends flavored vape sales in retail stores, quits social media; Google health unit to absorb DeepMind AI health division; Indegene launches digital agency.
A new study suggests creative departments are struggling to keep up data-driven advertising.
The shops were being probed after independent production companies accused advertising agencies of improper practices.
There has been more intrigue and discussion about the point-of-care environment over the past 18 months than in the last decade combined — and the news keeps on coming.
People are more inclined to change their lives for the better when content is motivational instead of based on shock-value, study finds.
Amarin CEO defends Vascepa trial results; Tech companies meet to discuss opioid epidemic; GSK to launch clinical program for pancreatic cancer.
Healthcare companies will have to rethink how they communicate online with millennials as the generation makes more healthcare decisions.
EngagedMedia’s General Manager Hoss Sooudi explains why real-time dynamic mobile messaging drives patient adherence.
Boyd has worked at AbbVie, Pfizer, and Schering-Plough.
Athenahealth sold for $5.7b; Driver shuts down; Combined Takeda-Shire could debut in January.
